134 related articles for article (PubMed ID: 38541302)
21. SARS-CoV-2 RNA may rarely be present in a uterine cervix LBC sample at the asymptomatic early stage of COVID 19 disease.
Ondič O; Černá K; Kinkorová-Luňáčková I; Němcová J; Mejchar B; Chytra J; Bouda J
Cytopathology; 2021 Nov; 32(6):766-770. PubMed ID: 34033165
[TBL] [Abstract][Full Text] [Related]
22. Factors related to inadequate cervical cancer screening in two Brazilian state capitals.
Martins LF; Valente JG; Thuler LC
Rev Saude Publica; 2009 Apr; 43(2):318-25. PubMed ID: 19287874
[TBL] [Abstract][Full Text] [Related]
23. [Pap smear coverage and factors associated with non-participation in cervical cancer screening: an analysis of the Cervical Cancer Prevention Program in Pernambuco State, Brazil].
Albuquerque KM; Frias PG; Andrade CL; Aquino EM; Menezes G; Szwarcwald CL
Cad Saude Publica; 2009; 25 Suppl 2():S301-9. PubMed ID: 19684937
[TBL] [Abstract][Full Text] [Related]
24. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
Hopkins KL; Jaffer M; Hlongwane KE; Otwombe K; Dietrich J; Cheyip M; Olivier J; Doherty T; Gray GE
PLoS One; 2021; 16(7):e0255124. PubMed ID: 34329334
[TBL] [Abstract][Full Text] [Related]
25. Challenges faced by cervical cancer prevention programs in developing countries: a situational analysis of program organization in Argentina.
Arrossi S; Paolino M; Sankaranarayanan R
Rev Panam Salud Publica; 2010 Oct; 28(4):249-57. PubMed ID: 21152712
[TBL] [Abstract][Full Text] [Related]
26. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer screening: A never-ending developing program.
Comparetto C; Borruto F
World J Clin Cases; 2015 Jul; 3(7):614-24. PubMed ID: 26244153
[TBL] [Abstract][Full Text] [Related]
28. Trends in cervical cancer and its precursor forms to evaluate screening policies in a mid-sized Northeastern Brazilian city.
Lima MS; Brito ÉAC; Siqueira HFF; Santos MO; da Silva AM; Nunes MAP; Brito HLF; Lima MMM; Cipolotti R; Lima CA
PLoS One; 2020; 15(5):e0233354. PubMed ID: 32428033
[TBL] [Abstract][Full Text] [Related]
29. Regional and social inequalities in the performance of Pap test and screening mammography and their correlation with lifestyle: Brazilian national health survey, 2013.
Theme Filha MM; Leal MD; Oliveira EF; Esteves-Pereira AP; Gama SG
Int J Equity Health; 2016 Nov; 15(1):136. PubMed ID: 27852313
[TBL] [Abstract][Full Text] [Related]
30. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
31. [Factors associated with lack of Pap smear screening in a group of postmenopausal Brazilian women].
Brischiliari SC; Dell'Agnolo CM; Gil LM; Romeiro TC; Gravena AA; Carvalho MD; Pelloso SM
Cad Saude Publica; 2012 Oct; 28(10):1976-84. PubMed ID: 23090176
[TBL] [Abstract][Full Text] [Related]
32. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
33. Coverage and focus of a cervical cancer prevention program in southern Brazil.
de Quadros CA; Victora CG; da Costa JS
Rev Panam Salud Publica; 2004 Oct; 16(4):223-32. PubMed ID: 15615596
[TBL] [Abstract][Full Text] [Related]
34. Case management intervention in cervical cancer prevention: the Boston REACH coalition women's health demonstration project.
Clark CR; Baril N; Hall A; Kunicki M; Johnson N; Soukup J; Lipsitz S; Bigby J
Prog Community Health Partnersh; 2011; 5(3):235-47. PubMed ID: 22080772
[TBL] [Abstract][Full Text] [Related]
35. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
36. Inequalities in Pap smear screening for cervical cancer in Brazil.
Martínez-Mesa J; Werutsky G; Campani RB; Wehrmeister FC; Barrios CH
Prev Med; 2013 Oct; 57(4):366-71. PubMed ID: 23827721
[TBL] [Abstract][Full Text] [Related]
37. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
38. Social inequalities in access to cancer screening and early detection: A population-based study in the city of São Paulo, Brazil.
Santos EFS; Monteiro CN; Vale DB; Louvison M; Goldbaum M; Cesar CLG; Barros MBA
Clinics (Sao Paulo); 2023; 78():100160. PubMed ID: 36681068
[TBL] [Abstract][Full Text] [Related]
39. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
40. Temporal pattern of tuberculosis cure, mortality, and treatment abandonment in Brazilian capitals.
Sousa GJB; Garces TS; Pereira MLD; Moreira TMM; Silveira GMD
Rev Lat Am Enfermagem; 2019; 27():e3218. PubMed ID: 31826160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
